Bluerock Acquisition Corp. II completes $172.5M IPO

The trust holds $173,362,500, with a public-share redemption trigger if no business combination is completed within 21 months of IPO closing.

Rhea-AI Filing Summary

Bluerock Acquisition Corp. II completed its IPO of 17,250,000 units at $10.00 each, generating $172,500,000 in gross proceeds. Each unit contains one Class A ordinary share and one-half of a redeemable warrant; each whole warrant is exercisable for one share at $11.50, beginning 30 days after an initial business combination is completed, subject to adjustment. The company also sold 5,812,500 private placement warrants at $1.00 each for $5,812,500 in gross proceeds.

The company placed $173,362,500 in trust, including up to $6,037,500 of the underwriter’s deferred commission. Except for interest that may be released to pay taxes and up to $100,000 of interest for liquidation expenses, trust funds are held until a business combination or specified redemptions, including if no combination is completed within 21 months of IPO closing. Christopher Bradley, Ziv Conen and Andrew Weksler were appointed independent directors and received 30,000, 25,000 and 40,000 Class B shares, respectively. The company will pay JBAAM, an affiliate of Andrew Weksler, up to $7,500 per month for no more than 12 months of administrative services.

Filing Explained

Effective September 24, the board’s three classes place Bradley and Conen’s terms to expire at the first annual meeting, Weksler’s at the second, and Kamfar’s at the third; Bradley, Conen and Weksler serve on Audit, which Weksler chairs, while Bradley and Conen serve on Compensation, which Conen chairs.

8-K Event Classification

6 items: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

6 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 3.02 Unregistered Sales of Equity Securities Securities

The company sold equity securities in a private placement or other unregistered transaction.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance

The company amended its charter documents, bylaws, or changed its fiscal year.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Units sold in IPO: 17,250,000 units IPO price: $10.00 per unit Gross IPO proceeds: $172,500,000 +5 more

8 metrics

Units sold in IPO 17,250,000 units IPO completed September 28, 2026

IPO price $10.00 per unit Completed IPO

Gross IPO proceeds $172,500,000 Completed IPO

Private placement warrants 5,812,500 warrants Sold concurrently with the IPO

Private placement warrant price $1.00 per warrant Private placement completed September 28, 2026

Gross private placement proceeds $5,812,500 Private placement completed with the IPO

Amount placed in trust $173,362,500 IPO and simultaneous private placement proceeds

Warrant exercise price $11.50 per share Each whole warrant is exercisable for one Class A ordinary share

Key Terms

initial business combination, over-allotment option, Private Placement Warrants, deferred commission, +1 more

5 terms

initial business combination financial

"completion of the Company’s initial business combination"

An initial business combination is the deal in which a special-purpose acquisition company (SPAC) merges with or acquires an operating business to bring that business onto public markets. Think of the SPAC as an empty shell that raises money from investors, then uses that cash to buy a private company—this transaction turns the private company into a public one and often changes its ownership, valuation, and access to capital, so investors should watch for shifts in risk, future growth prospects, and shareholder rights.

over-allotment option financial

"exercise of the underwriter’s over-allotment option in full"

An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.

Private Placement Warrants financial

"private sale of an aggregate of 5,812,500 warrants"

Private placement warrants are tradable coupons given directly to a limited group of investors that let the holder buy a company's shares at a fixed price before a set expiration date. They matter to investors because they can provide extra upside if the stock rises and give companies a way to raise money outside a public offering, but they also can increase the number of shares outstanding (dilution) and therefore affect share value and investor returns.

deferred commission financial

"up to $6,037,500 of the underwriter’s deferred commission"

trust account financial

"funds held in the trust account"

A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many units did BRRKU sell in its IPO?

Bluerock Acquisition Corp. II sold 17,250,000 units at $10.00 per unit, generating $172,500,000 in gross proceeds. The offering included 2,250,000 units issued through full exercise of the underwriter’s over-allotment option.

How much did BRRKU place in its trust account?

Bluerock placed $173,362,500 in trust, equal to $10.05 per public unit and including up to $6,037,500 of the underwriter’s deferred commission. Except for interest that may be released for taxes and up to $100,000 of interest for liquidation expenses, funds remain in trust until a business combination or a specified redemption, including if no combination is completed within 21 months of IPO closing.

What are the terms of BRRKU’s private placement warrants?

Bluerock sold 5,812,500 private placement warrants at $1.00 each, generating $5,812,500 in gross proceeds. Bluerock Acquisition Holdings II, LLC, the sponsor, purchased 3,862,500 warrants, and BTIG, LLC purchased 1,950,000. Each warrant is exercisable for one Class A ordinary share at $11.50.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/29/2026 - 04:12 PM Accepted by SEC EDGAR 09/29/2026 - 04:11 PM Learn about SEC filing dates

false --12-31 0002098410 00-0000000 0002098410 2026-09-24 2026-09-24 0002098410 tmb:UnitseachconsistingofoneClassAordinarysharedollar00001parvalueandonehalfofoneredeemablewarrantMember 2026-09-24 2026-09-24 0002098410 us-gaap:CommonClassAMember 2026-09-24 2026-09-24 0002098410 tmb:WarrantseachwholewarrantexercisableforoneClassAordinaryshareatanexercisepriceofdollar1150pershareMember 2026-09-24 2026-09-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 24, 2026

BLUEROCK ACQUISITION CORP. II

(Exact name of registrant as specified in its charter)

Cayman Islands		001-43485		N/A
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

919 Third Avenue

New York, New York 10022

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (212) 843-1601

Not Applicable
(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant		BRRKU		The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share		BRRK		The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share		BRRKW		The Nasdaq Stock Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 1.01. Entry into a Material Definitive Agreement.

On September 28, 2026, Bluerock Acquisition Corp. II (the “Company”) consummated its initial public offering (“IPO”) of 17,250,000 units (the “Units”), including the issuance of 2,250,000 Units as a result of the underwriter’s exercise of the over-allotment option in full. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-half of one redeemable warrant of the Company (each whole warrant, a “Warrant”), with each Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, subject to adjustment, beginning 30 days after the completion of the Company’s initial business combination. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $172,500,000.

In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s Registration Statement on Form S-1 (File No. 333-297691) for the IPO, initially filed with the U.S. Securities and Exchange Commission (the “Commission”) on July 24 2026, as amended (the “Registration Statement”):

● An Underwriting Agreement, dated September 24, 2026, by and between the Company and BTIG, LLC, as representative of the underwriters (the “Representative”), a copy of which is attached as Exhibit 1.1 hereto and is incorporated herein by reference.

● A Warrant Agreement, dated September 24, 2026, by and between the Company and Continental Stock Transfer & Trust company (“Continental”), as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and is incorporated herein by reference.

● A Letter Agreement, dated September 24, 2026, by and among the Company, its executive officers, its directors and Bluerock Acquisition Holdings II, LLC, the Company’s sponsor (the “Sponsor”), a copy of which is attached as Exhibit 10.1 hereto and is incorporated herein by reference.

● An Investment Management Trust Agreement, dated September 24, 2026, by and between the Company and Continental, as trustee, a copy of which is attached as Exhibit 10.2 hereto and is incorporated herein by reference.

● A Registration Rights Agreement, dated September 24, 2026, by and among the Company, the Sponsor and the holders signatory thereto, a copy of which is attached as Exhibit 10.3 hereto and is incorporated herein by reference.

● A Private Placement Warrants Purchase Agreement, dated September 24, 2026, by and between the Company and the Sponsor (the “Sponsor Private Placement Warrants Purchase Agreement”), a copy of which is attached as Exhibit 10.4 hereto and is incorporated herein by reference.

● A Private Placement Warrants Purchase Agreement, dated September 24, 2026, by and between the Company and the Representative (the “Representative Private Placement Warrants Purchase Agreement” and, together with the Sponsor Private Placement Warrants Purchase Agreement, the “Private Placement Warrants Purchase Agreements”), a copy of which is attached as Exhibit 10.5 hereto and is incorporated herein by reference.

● An Administrative Services and Indemnification Agreement, dated September 24, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.6 hereto and is incorporated herein by reference.

● An Administrative Services Agreement, dated September 24, 2026, by and between the Company and JBA Asset Management LLC (“JBAAM”), a copy of which is attached as Exhibit 10.7 hereto and is incorporated herein by reference.

The material terms of such agreements are fully described in the Company’s final prospectus, dated September 24, 2026, as filed with the Commission on September 25, 2026 (the “Prospectus”) and are incorporated herein by reference.

1

Item 3.02. Unregistered Sales of Equity Securities.

On September 28, 2026, simultaneously with the closing of the IPO, pursuant to the Private Placement Warrants Purchase Agreements, the Company completed the private sale of an aggregate of 5,812,500 warrants (the “Private Placement Warrants”) to the Sponsor and the Representative at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $5,812,500. Of the 5,812,500 Private Placement Warrants, the Sponsor purchased 3,862,500 Private Placement Warrants and the Representative purchased 1,950,000 Private Placement Warrants. The Private Placement Warrants are identical to the Warrants included as part of the Units sold in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to the sale of the Private Placement Warrants. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 24, 2026, in connection with the IPO, Christopher Bradley, Ziv Conen and Andrew Weksler were appointed to the board of directors of the Company. Each of Christopher Bradley, Ziv Conen and Andrew Weksler are independent directors. Effective September 24, 2026, Christopher Bradley, Ziv Conen and Andrew Weksler were appointed to the Board’s Audit Committee and Christopher Bradley and Ziv Conen were appointed to the Board’s Compensation Committee, with Andrew Weksler and Ziv Conen serving as chair of the Audit Committee and chair of the Compensation Committee, respectively.

Following the appointment of Messrs. Bradley, Conen and Weksler, the Board is comprised of three classes. The term of office of the first class of directors, Class I, consisting of Christopher Bradley and Ziv Conen, will expire at the Company’s first annual meeting of shareholders. The term of office of the second class of directors, Class II, consisting of Andrew Weksler, will expire at the Company’s second annual meeting of shareholders. The term of office of the third class of directors, Class III, consisting of R. Ramin Kamfar, will expire at the Company’s third annual meeting of shareholders.

On September 24, 2026, in connection with their appointments to the Board, each of the members of the Board entered into the Letter Agreement as well as an indemnity agreement with the Company in the form previously filed as Exhibit 10.6 to the Registration Statement. In addition, Christopher Bradley received 30,000 Class B ordinary shares of the Company, Ziv Conen received 25,000 Class B ordinary shares of the Company and Andrew Weksler received 40,000 Class B ordinary shares of the Company as compensation for their service as directors to the Company.

On September 24, 2026, in connection with the IPO, the Company and JBAAM, an affiliate of Andrew Weksler, entered into the Administrative Services Agreement, pursuant to which the Company will pay JBAAM up to $7,500 per month for a maximum of twelve months for office space, secretarial and administrative services.

Other than the foregoing, none of the directors are party to any arrangement or understanding with any person pursuant to which they were appointed as directors, nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.

The foregoing descriptions of the Letter Agreement, the form of indemnity agreement, and the Administrative Services Agreement do not purport to be complete and are qualified in their entireties by reference to the Letter Agreement, the form of indemnity agreement, and the Administrative Services Agreement, copies of which are attached as Exhibit 10.1 hereto and as Exhibit 10.6 and Exhibit 10.10 to the Registration Statement, respectively, and are incorporated herein by reference.

Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.

On September 24, 2026, in connection with the IPO, the Company adopted its Fourth Amended and Restated Memorandum and Articles of Association (the “Amended Articles”), effective the same day. The terms of the Amended Articles are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Amended Articles is attached as Exhibit 3.1 hereto and incorporated herein by reference.

2

Item 8.01. Other Events.

A total of $173,362,500 of the net proceeds from the IPO (which amount includes up to $6,037,500 of the underwriter’s deferred commission) ($10.05 per Unit) and the sale of the Private Placement Warrants, was placed in a U.S.-based trust account maintained by Continental, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its taxes and up to $100,000 of interest to pay liquidation expenses, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination or an earlier redemption in connection with the commencement of the consummation of the initial business combination if the Company determines it is desirable to facilitate the completion of the initial business combination, (ii) the redemption of the Class A Ordinary Shares included in the Units sold in the IPO (the “public shares”) if the Company is unable to complete its initial business combination within 21 months from the closing of the IPO , subject to applicable law or (iii) the redemption of any of the public shares properly submitted in connection with a shareholder vote to amend the Company’s Amended Articles (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial business combination or to redeem 100% of its public shares if it has not consummated an initial business combination within 21 months from the closing of the IPO or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity.

On September 24, 2026, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

On September 28, 2026, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

EXHIBIT INDEX

Exhibit No.		Description
1.1		Underwriting Agreement, dated September 24, 2026, by and between the Company and the Representative.
3.1		Fourth Amended and Restated Memorandum and Articles of Association.
4.1		Warrant Agreement, dated September 24, 2026, by and between the Company and Continental, as warrant agent.
10.1		Letter Agreement, dated September 24, 2026, by and among the Company, its executive officers, its directors and the Sponsor.
10.2		Investment Management Trust Agreement, dated September 24, 2026, by and between the Company and Continental, as trustee.
10.3		Registration Rights Agreement, dated September 24, 2026, by and among the Company, the Sponsor and the Holders signatory thereto.
10.4		Private Placement Warrants Purchase Agreement, dated September 24, 2026, by and between the Company and the Sponsor.
10.5		Private Placement Warrants Purchase Agreement, dated September 24, 2026, by and between the Company and the Representative.
10.6		Administrative Services and Indemnification Agreement, dated September 24, 2026, by and between the Company and the Sponsor.
10.7		Administrative Services Agreement, dated September 24, 2026, by and between the Company and JBAAM.
99.1		Press Release, dated September 24, 2026.
99.2		Press Release, dated September 28, 2026.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	BLUEROCK ACQUISITION CORP. II
	By:	/s/ Harrison Seideman
		Name:	Harrison Seideman
		Title:	President and Chief Operating Officer
Dated: September 29, 2026

4

Exhibit 99.1 

Bluerock Acquisition Corp. II Announces Pricing of $150 Million Initial Public Offering

September 24, 2026 / Bluerock Acquisition Corp. II Press Release

NEW YORK, NY (September 24, 2026) - Bluerock Acquisition Corp. II (the “Company”) today announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market “Nasdaq”) and are expected to trade under the ticker symbol “BRRKU” beginning on September 25, 2026. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “BRRK” and “BRRKW,” respectively. The offering is expected to close on September 28, 2026.

Bluerock Acquisition Corp. II is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an initial business combination in any business or industry.

BTIG, LLC is acting as the sole book-running manager for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 2,250,000 units at the initial public offering price to cover over- allotments, if any.

A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on September 24, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained, when available, from BTIG, LLC, 65 East 55th Street, New York, NY 10022, by email at: ProspectusDelivery@btig.com, or by visiting the SEC’s website at www.sec.gov.

FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering and the anticipated use of the net proceeds from the offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated, or that the Company will ultimately complete a business combination transaction. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

INVESTOR CONTACT

Harrison Seideman

spac@bluerock.com

MEDIA CONTACT

Carly Hampton

champton@bluerock.com

Exhibit 99.2

Bluerock Acquisition Corp. II Announces Closing of $172.5 Million Initial Public Offering Including Exercise of Underwriter’s Over-Allotment Option in Full

 

NEWS PROVIDED BY 

Bluerock Acquisition Corp. II  

Sep 28, 2026, 13:36 ET

NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Bluerock Acquisition Corp. II (Nasdaq: BRRKU) (the “Company”) today announced the closing of its initial public offering of 17,250,000 units, which includes 2,250,000 units issued pursuant to the exercise by the underwriter of its over-allotment option in full, at a public offering price of $10.00 per unit. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share.

The units are listed on The Nasdaq Global Market (“Nasdaq”) and commenced trading under the ticker symbol “BRRKU” on September 25, 2026. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “BRRK” and “BRRKW,” respectively.

Concurrently with the closing of the initial public offering, the Company closed on a private placement of 5,812,500 warrants at a price of $1.00 per warrant, resulting in gross proceeds of $5,812,500. Bluerock Acquisition Holdings II, LLC, the Company’s sponsor, purchased 3,862,500 of the private placement warrants and BTIG, LLC purchased 1,950,000 of the private placement warrants. Each private placement warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of warrants, $173,362,500 (or $10.05 per unit sold in the public offering) was placed in trust.

Bluerock Acquisition Corp. II is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an initial business combination in any

business or industry.

“With the successful pricing of Bluerock Acquisition Corp. II, our second SPAC vehicle, we believe we offer a compelling value proposition to prospective companies considering a path to the public markets,” said Harrison Seideman, President and Chief Operating Officer of Bluerock Acquisition Corp. II. “Building on the platform we established with our first vehicle, we intend to focus our sourcing efforts on companies at an inflection point in their growth trajectory seeking a strategic capital partner.”

BTIG, LLC acted as the sole book-running manager for the offering. 

A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on September 24, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering was made only by means of a prospectus. Copies of the prospectus relating to this offering may be obtained from BTIG, LLC, 65 East 55th Street, New York, NY 10022, by email at: ProspectusDelivery@btig.com, or by visiting the SEC’s website at www.sec.gov.

Cautionary Note Concerning Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the Company’s search for an initial business combination and the anticipated use of the net proceeds of the initial public offering and simultaneous private placement. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement for the initial public offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

 

Contacts

Investor Contact:

Harrison Seideman

spac@bluerock.com

Media Contact:

Carly Hampton

CHampton@bluerock.com

SOURCE Bluerock Acquisition Corp. II

Filing Exhibits & Attachments

16 documents

Press Releases

• EX-99.1 EXHIBIT 99.1 11.0 KB
• EX-99.2 EXHIBIT 99.2 11.1 KB

Agreements & Contracts

• EX-10.1 EXHIBIT 10.1 47.4 KB
• EX-10.2 EXHIBIT 10.2 86.4 KB
• EX-10.3 EXHIBIT 10.3 124.9 KB
• EX-10.4 EXHIBIT 10.4 45.5 KB
• EX-10.5 EXHIBIT 10.5 50.8 KB
• EX-10.6 EXHIBIT 10.6 17.1 KB
• EX-10.7 EXHIBIT 10.7 10.9 KB

Other Documents

• EX-1.1 EXHIBIT 1.1 240.9 KB
• EX-3.1 EXHIBIT 3.1 354.3 KB
• EX-4.1 EXHIBIT 4.1 154.3 KB
• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 3.9 KB
• EX-101 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE 26.7 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 38.5 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 25.4 KB